Sonnet BioTherapeutics Holdings, Inc. Gains 38.41%

Thu, May 25, 2023 at 07:45 PM
Sonnet BioTherapeutics Holdings, Inc. Gains 38.41%

Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) rocketted at $0.4, a gain of 38.4%. On Thu, May 25, 2023, SONN:NASDAQ hit a New 2-Week High of $0.4. The stock got featured on our News Catalysts scanner on Wed, May 10, 2023 at 08:39 AM in the 'INVESTOR UPDATE' category. From Thu, May 11, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Mon, Jan 09, 2023 at $1.68 with a volume of 15M+.

About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)

Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.